Search

6990 results for: ‘独立版校园跑腿校园社区小程序系统源码提供定制开发✅项目合作 二开均可 TG:saolei44✅.YgxhcXIXUmRdu’

  • The Muslim veil: a symbol of terror?

    Read the article "The Muslim veil: a symbol of terror?" This is part of the Social Worlds project at the University of Leicester.

  • English PGCE

    English is a core subject within the secondary curriculum. The English PGCE (M) and (H) level courses aim to prepare you to meet QTS standards fully, and to learn to teach the 11-19 English/Media curriculum with confidence, authority and enthusiasm.

  • Who was Richard III?

    A brief primer on the last Plantagenet king of England and his links with Leicester.

  • Diabetes patch proposal wins award for University of Leicester PhD student

    Charlotte Fawcett, a PhD student from the University of Leicester Department of Cardiovascular Sciences, led a business proposal that has won an award in the Young Entrepreneurs Scheme.

  • Space Park Leicester and NCEO welcome the community to COP28 celebration

    A Community Opening Evening will take place at Space Park Leicester, featuring an array of stands, displays, and activities presented by the University and its partners on 6 December

  • National planetary science conference launches in Leicester

    The British Planetary Science Conference 2024 launches at Space Park Leicester

  • Patient safety

    Overview Patient safety is defined as the prevention, avoidance and amelioration of harms stemming from medical mismanagement and is traditionally viewed through a clinical lens.

  • Dr Simon Leader

    Roger Dickinson and Jim McKenna write: We have learned, with great regret, of the sudden and unexpected death of Dr Simon Leader at the age of 53.

  • Transforming scholarship

    The Centre for Hate Studies is renowned for undertaking pioneering and transformative research.

  • COVID-19 treatment trialed at Leicester’s Hospitals shown to reduce deaths in sickest patients by one-fifth

    John, a self-employed roofer, was approached by a research nurse to take part in the RECOVERY trial, where he was assigned the Regeneron monoclonal antibody combination. The treatment was delivered through an intravenous drip, which took about an hour to enter his body.

Back to top
MENU